• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ghana: 2022 Marburg Virus disease

Shiloh

Editor, Senior Moderator
Source: https://www.myjoyonline.com/two-sus...virus-disease-recorded-in-ashanti-region-ghs/

Two suspected cases of Marburg Virus disease recorded in Ashanti Region – GHS
Source: Myjoyonline.com
7 July 2022 8:00pm

The Ghana Health Service (GHS) has announced the discovery of two suspected cases of Marburg Virus disease in the Ashanti Region following a test conducted on the victims.

According to the GHS, blood samples of the two persons were taken for examination after they had shown signs of Acute Haemorrhagic Fever.

“Preliminary results suggest the infection is due to the Marburg virus,” GHS said in a statement on July 7...
 
Source: https://www.afro.who.int/countries/...st-ever-suspected-cases-marburg-virus-disease

Ghana reports first-ever suspected cases of Marburg virus disease


07 July 2022
Accra – Ghana has announced the preliminary finding of two cases of Marburg virus disease and if confirmed these would the first such infections recorded in the country. Marburg is a highly infectious viral haemorrhagic fever in the same family as the more well-known Ebola virus disease.
Preliminary analysis of samples taken from two patients by the country’s Noguchi Memorial Institute for Medical Research indicated the cases were positive for Marburg. However, per the standard procedure, the samples have been sent to the Institut Pasteur in Senegal, a World Health Organization (WHO) Collaborating Centre for confirmation. The two patients from the southern Ashanti region – both deceased and unrelated – showed symptoms including diarrhoea, fever, nausea and vomiting. They had been taken to a district hospital in Ashanti region.
Preparations for a possible outbreak response are being set up swiftly as further investigations are underway.
“The health authorities are on the ground investigating the situation and preparing for a possible outbreak response. We are working closely with the country to ramp up detection, track contacts, be ready to control the spread of the virus,” said Dr Francis Kasolo, World Health Organization (WHO) Representative in Ghana.
WHO is deploying experts to support Ghana’s health authorities by bolstering disease surveillance, testing, tracing contacts, preparing to treat patients and working with communities to alert and educate them about the risks and dangers of the disease and to collaborate with the emergency response teams.
If confirmed, the cases in Ghana would mark the second time Marburg has been detected in West Africa. Guinea confirmed a single case in an outbreak that was declared over on 16 September 2021, five weeks after the initial case was detected.
Previous outbreaks and sporadic cases of Marburg in Africa have been reported in Angola, the Democratic Republic of the Congo, Kenya, South Africa and Uganda.
Marburg is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials. Illness begins abruptly, with high fever, severe headache and malaise. Many patients develop severe haemorrhagic signs within seven days. Case fatality rates have varied from 24% to 88% in past outbreaks depending on virus strain and case management.
Although there are no vaccines or antiviral treatments approved to treat the virus, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improves survival. A range of potential treatments, including blood products, immune therapies and drug therapies, are being evaluated.
 
Source: https://globalnews.ca/news/8996712/marburg-outbreak-ghana-world-health-organization/

WHO declares highly-infectious Marburg virus outbreak in Ghana
By Staff The Associated Press
Posted July 17, 2022 3:49 pm

The World Health Organization has declared Ghana‘s first outbreak of the Ebola-like Marburg virus disease after labs confirmed the infections in two cases announced earlier this month.

The disease, a very infectious hemorrhagic fever in the same family as Ebola, is spread to people by fruit bats and transmitted among people through direct contact with bodily fluids of infected people and surfaces, WHO said.

A preliminary analysis of samples from two patients from Ghana’s southern Ashanti region – both of whom died and were unrelated – turned up positive, but were forwarded for full confirmation to the Institute Pasteur in Dakar, Senegal. That U.N. health agency lab corroborated the results from the Noguchi Memorial Institute for Medical Research in Ghana, WHO said in a statement Sunday.

The first case was a 26-year-old male who checked into a hospital on June 26 and died on June 27. The second was a 51 -year-old male who went to the hospital on June 28 and died the same day, WHO said, adding that both men sought treatment at the same hospital.

“Health authorities have responded swiftly, getting a head start preparing for a possible outbreak,” said WHO Regional Director for Africa Dr. Matshidiso Moeti. “This is good because without immediate and decisive action, Marburg can easily get out of hand. WHO is on the ground supporting health authorities and now that the outbreak is declared, we are marshalling more resources for the response.”..
 
Ministry of Health, Ghana


Yesterday at 2:20 PM ·
203c.png
PRESS RELEASE
203c.png

Ghana Confirms Marburg Virus Disease (MVD)

294255416_348530450783512_7423529130709641504_n.jpg

Ghana Confirms Marburg Virus Disease (MVD)
294255416_348530450783512_7423529130709641504_n.jpg

294255416_348530450783512_7423529130709641504_n.jpg

294478801_348641784105712_460052618626215609_n.jpg

294478801_348641784105712_460052618626215609_n.jpg

294478801_348641784105712_460052618626215609_n.jpg
 
Last edited:
Source: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON402


Marburg virus - Ghana

22 July 2022


Outbreak at a glance


Two fatal cases of Marburg virus disease (MVD) were reported from Ashanti region, Ghana. On 28 June 2022, these cases were notified to health authorities as suspected viral hemorrhagic fever (VHF) cases and tested positive for Marburg virus on 1 July 2022. An outbreak of MVD has only been reported once previously in West Africa, and this is the first time MVD has been notified in Ghana. An outbreak of MVD may represent a serious public health threat as it is severe and often fatal.

Description of the outbreak


On 28 June 2022, two suspected viral hemorrhagic fever (VHF) cases were notified to health authorities in the Ashanti region, Ghana (Figure 1). This region is located in the middle belt of Ghana and is the most populated region in the country.

The first case was a 26-year-old male who was a farm worker in Adansi North district, Ashanti region with a travel history to the Western region. Prior to symptom onset on 24 June, he arrived from the Western region to Ashanti region. He sought care at a hospital on 26 June and died on 27 June. The case was transported and buried in the Sawla-Tuna-Kalba district, Savannah region, which borders both Burkina Faso and Côte d’Ivoire. The burial was conducted before the results of laboratory tests for MVD were available.

The second case was a 51-year-old male who was a farm worker in Bekwai Municipal, Ashanti region. He sought care at the same hospital as the first case on 28 June but died the same day.

Both cases presented with fever, general malaise, bleeding from the nose and mouth, and subconjunctival bleeding (bleeding of the blood vessels in the eyes). Blood samples were collected on 27 June for the first case and 28 June for the second case and sent to Noguchi Memorial Institute of Medicine Research (NMIMR) for testing. On 1 July, both cases tested positive for Marburg virus by reverse transcriptase polymerase chain reaction (RT-PCR). On 12 July, samples collected from the two cases were sent to Institute Pasteur in Dakar, Senegal (IPD) which confirmed the results from NMIMR on 14 July 2022.

Figure 1. Region of the two confirmed cases of Marburg virus disease reported in Ghana, as of 20 July 2022


The source of infection is unknown. Preliminary investigations have shown that neither of these cases had a history of contact with dead animals, sick persons, or animals and had not attended any social gathering within three weeks of symptoms onset. Although both cases were farmers, they worked in different locations, and they have not been found to be epidemiologically linked. However, both cases came from communities living in a forest environment.


A cumulative number of 108 individuals (50 from Ashanti region, 48 from Savannah region, and 10 from the Western region) were identified as contacts of the two cases, all of whom were under self-quarantine and daily monitoring for 21 days. On 20 July, all contacts completed their follow up period. These contacts included health care workers and immediate family members of the cases. One contact reported some symptoms, but a blood sample that was collected tested negative at NMIMR on 7 July. All the other contacts reported to be in good health during the follow up period.

Epidemiology of the disease

MVD is an epidemic-prone disease associated with high case fatality ratios (CFR; 24-88%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from many other tropical febrile illnesses due to the similarities in the clinical symptoms. Other VHFs need to be excluded, particularly Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infections, and plague. Human MVD infection can result from prolonged exposure to mines or caves inhabited by Rousettus bat colonies. Marburg virus spreads through human-to-human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials (e.g., bedding, clothing) contaminated with these fluids.


Although there are no vaccines or antiviral treatments approved to treat the virus, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improve survival. A range of potential treatments, including blood products, immune therapies, and drug therapies, are being evaluated.

In 2021, an outbreak of MVD was reported for the first time in Guinea.


Public health response

National and international coordination involving key partners are ongoing to respond to this outbreak.
  • The Ministry of Health of Ghana is coordinating response activities and is engaging with partners for support, as needed.
  • The Ashanti region health directorate established coordination mechanisms in the affected health districts and response activities have commenced. 
  • Epidemiological investigations continue to be conducted, including enhanced surveillance using the Integrated disease surveillance and Response (IDSR) system and follow-up of contacts.  Eight alerts have been reported from Ashanti, Oti and Western regions. Following investigations, seven alerts were discarded and one alert from Oti region tested positive for yellow fever.
  • Sensitization activities of health care workers on case definition and infection prevention and control measures are ongoing. 
  • The NMIMR laboratory has the capacity to test for viral hemorrhagic fevers and is testing samples resulting from alerts. To date, 15 samples were tested for Marburg virus, and all samples tested negative. Sequencing of the virus is ongoing.
  • A designated hospital has been identified in Ashanti region to isolate and care for additional cases.
  • WHO is deploying technical experts to support the country in strengthening Infection Prevention and Control (IPC), coordination, surveillance, and conducting investigations assessing risks for further outbreaks.
  • An orientation has been held for community-based surveillance volunteers to enhance surveillance at the community level.
  • WHO is offering testing support in the form of supplying reagents to NMIMR which first tested the samples.
  • Côte d’Ivoire and Burkina Faso have been informed of the event and are initiating preparedness activities.











WHO risk assessment

The risk of this outbreak is high at the national level, moderate at the regional level, and low at the global level. The notification of two confirmed cases of MVD with a CFR of 100% (2/2) raises concern. The epidemiological investigation has not yet identified the source of this outbreak, which highlights the need to intensify the community-based surveillance. 

There is a risk for this outbreak to spread to neighboring countries because the first case travelled from Western region prior to symptoms onset. The Western region shares a border with Côte d’Ivoire, and this may present a risk of transborder transmission if more cases continue to be reported or affect other areas. In addition, the first case was not buried safely in Savannah region which also borders Côte d’Ivoire and Burkina Faso. Therefore, WHO has assessed the risk of this outbreak as high at the national level, moderate at the regional level, and low at the global level. 



WHO advice

Community engagement activities need to be carried out in the three identified regions in Ghana (Ashanti, Savannah and Western regions) with a particular focus on providing adequate information and support for the population to implement measures to prevent further transmission, avoid stigmatization within the community, and encourage early presentation to treatment centers and other necessary outbreak containment measures, including safe burials.


It is also important to raise awareness of the risk factors for MVD infection and the protective measures that individuals can take to reduce human exposure to the virus. Key public health communication messages include:
  • Reducing the risk of human-to-human transmission in the community arising from direct or close contact with infected patients, particularly with their body fluids. Close physical contact with Marburg patients should be avoided. Gloves and appropriate personal protective equipment should be worn when taking care of ill patients at home. Regular hand washing should be performed after visiting sick relatives in hospital, as well as after taking care of ill patients at home.
  • Reducing the risk of bat-to-human transmission. Handle wildlife with gloves and other appropriate protective clothing. Cook animal products (blood and meat) thoroughly before consumption and avoid consuming raw meat. During work, research activities, or tourist visits in mines or caves inhabited by fruit bat colonies, wear gloves and other appropriate protective clothing including masks.
Outbreak containment measures should be continued and strengthened in the three regions of Ghana. These measures include:
  • Maintaining and building trust with communities
  • Scaling-up surveillance activities (active case search, contact monitoring, and investigation)
  • Testing all suspected cases of MVD in a timely manner
  • Ensuring that adequate infection prevention and control measures are implemented when caring for suspected, probable and confirmed patients
  • Isolating early, and caring for suspected and confirmed cases, if possible, in designated health facilities with trained health workers and adequate IPC measures.
  • Performing safe and dignified burial of deceased individuals who are probable or confirmed cases of MVD.
Marburg virus transmission has previously been reported in health care settings when appropriate infection prevention and control (IPC) measures were not implemented. IPC measures to reduce risk of transmission in health care include:
  • Establish an IPC task force in the health zone to ensure implementation of the Infection prevention and control activities
  • Ensure health workers are briefed on MVD (standard and transmission-based precautions) including an emphasis on safe injection practices
  • Ensure minimum WASH and isolation requirements and capacity are met in health facilities.
Based on the current risk assessment WHO advises against any restriction of travel and trade to Ghana.

Further information

For further information, please see:
 
Source: https://www.myjoyonline.com/marburg-virus-1-more-person-dies-40-quarantined-in-ghana/


Marburg virus: 1 more person dies; 40 quarantined in Ghana
Source: Ernest Arhinful
25 July 2022 8:35am

One more person has died of the Marburg virus with 40 others quarantined in the Savannah Region.

The person died on Thursday, July 21.

He is said to be a relative of one of the two people who died from the virus in June.

The two people died days apart after reporting to the hospital with hemorrhagic fever.

The Ghana Health Service (GHS) has disclosed that he showed symptoms of the Marburg virus days after the stipulated incubation period...
 
Source: https://www.graphic.com.gh/news/gen...pdate-3-cases-2-deaths-recorded-in-ghana.html

Marburg Virus Disease update: 3 cases, 2 deaths recorded in Ghana
Date: Jul - 29 - 2022 , 11:38
BY: Kweku Zurek


The Ghana Health Service (GHS) has announced that three confirmed cases of the Marburg Virus Disease have been recorded in the country with two persons dying from the illness.

All three cases are related; a father, mother and son.

The GHS release comes a day after the Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus in a tweet said Ghana had recorded four cases and three deaths.

However, the GHS said repeat test results received from Noguchi Memorial Institute for Medical Research (NMIMR) on one of the suspected cases had confirmed that it was a false positive.

"The Ghana Health Service on Sunday, 24 July, 2022 reported four cases of Marburg Virus Disease (MVD) following test results from the Noguchi Memorial Institute for Medical Research (NMIMR)," the release said.

"The second case, a 51-year-old male with a known chronic disease and not linked to the first case was, however, awaiting re-testing. Repeat test results received from NMIMR on 28 July 2022 were negative for MVD, bringing the total number of confirmed cases to three (3)".

Cases

The Ghana Health Service in a press release issued on July 28, 2022, said the father, a 26-year-old male, got ill on June 22, 2022, and later bled from the nose and moth and was admitted to a hospital in the Ashanti Region on June 26, 2022 and died 28 hours after admission.

Similarly, the son, a one-year two-month-old got ill and was admitted on July 17, 2022. He died on the third day of admission.

The mother, a 24-year-old female is alive and well and has since Tuesday, July 26, 2022, been in a government-designated isolation centre, and is being managed with full implementation of strict infection prevention and control measures....
 
Ghana Health Service Official
@_GHSofficial
·17h
❗️PRESS RELEASE ❗
Update on Marburg Virus Disease Outbreak in Ghana

FYxxpZEWIAEiEmg


FYxxpZPXgAUGOhy
 
Source: https://www.swissinfo.ch/eng/child-infected-with-marburg-virus-dies-in-ghana/47797220

Child infected with Marburg virus dies in Ghana
This content was published on August 2, 2022 - 10:44 August 2, 2022 - 10:44

GENEVA (Reuters) -A child who contracted the highly infectious Ebola-like Marburg virus in Ghana has died, a World Health Organization official said on Tuesday.

The death brings the total number of fatalities in the country to three since Ghana registered its first ever outbreak of the disease last month.

The outbreak is only the second in West Africa. The first ever case of the virus in the region was detected last year in Guinea...
 
As per above, there were no previously reported alive child cases. So I would assume this represents an additional confirmed case as well.
 
WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES

Week 31: 25 - 31 July 2022
Data as reported by: 17:00; 31 July 2022

...

Marburg virus disease Ghana

4 cases
3 Death
75% CFR


EVENT DESCRIPTION

A Marburg virus disease (MVD) outbreak continues in the
Ashanti region of Ghana with two new cases reported in the past
week. Blood samples from both cases tested positive by reverse
transcriptase polymerase chain reaction (RT-PCR) at the Noguchi
Memorial Institute of Medicine Research (NMIMR) laboratory.
Both cases were close contacts of the first case. They developed
symptoms and tested positive for MVD at the NMIMR on 22 July
2022. The third case was a 22-year-old female, wife of the first
case, who started presenting with headache on 29 June. As of
24 July, she had not been found by the investigation team. The
fourth case was a 1-year-old child, son of the first and third cases.
He had onset of symptoms of diarrhoea on 13 July 2022 and he
reportedly died on 19 July.

As of 29 July 2022, four confirmed cases with three deaths (case
fatality ratio 75%) have been reported in the Ashanti region,
Ghana. All the 118 contacts of the two initial cases completed their
21-days of follow up on 21 July 2022. These contacts included;
50 from the Ashanti Region, 20 from the Western Region and 48
from the Savannah Region. Most of them (99; 84%) were close
family members or community (including household) contacts
while 19 (16%) were health care workers.

Following the detection of the two further confirmed cases, 40
additional contacts have been identified in the Savannah Region
and are under close-monitoring. Eleven (28%) of the 40 contacts
are health care workers.

PUBLIC HEALTH ACTIONS

National-level coordination meetings with the ministry of
health, partners (WHO, US CDC and UNICEF), Foreign,
Commonwealth and Development Office (FCDO) and the
Wildlife Division of the Veterinary Service have been held
Regional Public Health Emergency Committees were
activated. Outbreak response coordination mechanisms
have been activated in the Ashanti Region and district levels

A health alert has been sent to all Regions, health facilities
and teaching hospitals

Case definitions, including community case definitions
and fact sheets for MVD have been distributed to all health
facilities.

WHO country office supporting with transportation
of specimen to Institute Pasteur in Dakar, Senegal for
confirmation.

MVD surveillance is heightened across the country,
community-based surveillance volunteers in the Adansi
North District have been engaged to support community
level case search.

Contact tracing and active case search in communities and
health facilities are ongoing.

The national testing site has been linked with the WHO
Regional Office for Africa laboratory focal point for logistical
support

Clinician sensitization on-going on case detection,
management, and infection prevention. Case management
needs assessment on-going.

SITUATION INTERPRETATION

Ghana continues to respond to a Marburg virus disease outbreak.
More confirmed cases linked to the first case have been reported,
even when the source of infection is unknown. The WHO and
other partners continue to support Ghana’s health authorities
by deploying experts, making available personal protective
equipment, reinforcing disease surveillance, testing, tracing
contacts and working with communities to alert and educate them
about the risks and dangers of the disease, and to collaborate
with the emergency response teams

https://apps.who.int/iris/bitstream/handle/10665/361243/OEW31-2531072022.pdf
 
GTonline
August 8, 2022

Report signs of Marburg Virus Disease …GHS advises public
...
According to the Ghana Health Service (GHS), a fourth suspected case was currently being investigated, urging citizens to report any sudden illness at the health facilities to contain further spread of the disease.

The Director-General, Dr Patrick Kuma-Aboagye, gave the advice in an interview with the Ghanaian Times last Friday.
...
“Do not wait to start bleeding before you report at the health centre and we advise that for all suspicious deaths, call health workers to find out the cause of death before handling the body even if it is an animal,” the DG of GHS said.
...
He said all contacts traced to confirmed cases have so far tested negative to the virus adding that “the mother of the second case who is also wife of the first case, is still healthy and showing no sign of illness.”

“She is in isolation and we continue to run tests on her. We are hoping that if the next test turns out negative, we can discharge her,” he stated.
...
Of the three confirmed cases in the country, all involving one family, father and son have died with mother under treatment for full recovery.

BY ABIGAIL ANNOH

https://www.ghanaiantimes.com.gh/report-signs-of-marburg-virus-disease-ghs-advises-public/
 
Ghana Health Service@_GHSofficial
·Aug 12
❗PRESS RELEASE ❗
Recovery of the Last Case of Marburg Virus Disease in Ghana


FZ8SUdEXoAIUfcK
 
Source: https://menafn.com/1104694126/Ghana-announces-that-there-are-no-active-cases-of-Marburg-virus


Ghana announces that there are no active cases of Marburg virus
Date
8/14/2022 7:18:50 AM


(MENAFN) Following the recovery of the final affected person, Ghana stated on Friday that there are no current instances of the Marburg virus, which is similar to Ebola.

The Ghana Health Service's declaration adheres to World Health Organization regulations, which state that a nation shall be deemed free of the outbreak if there are no new cases 42 days following the final negative test.

Ghana verified its first case of the Marburg virus sickness on July 4, according to the health department. Since then, three cases and two fatalities have been documented...
 
WEEKLY BULLETIN ON OUTBREAKS
AND OTHER EMERGENCIES

Week 38: 12 - 18 September 2022
Data as reported by: 17:00; 18 September 2022

...
Marburg Virus Ghana

3 cases
2 Deaths
66.7% CFR


EVENT DESCRIPTION

Ghana declared its first ever Marburg Virus Disease (MVD)
outbreak on 7 July 2022. The first reported case in the country
was a 26-year-old male who resided in Adansi North District of
the Ashanti Region. He presented at a hospital on 26 June 2022
with history of vomiting, bloody diarrhoea, fever, chills, general
malaise, dysuria, bleeding from the nose and mouth, and swelling
of the eyes with subconjunctival bleeding.

He was diagnosed as a case of upper gastrointestinal bleed (to
rule out Viral Haemorrhagic Fever) and managed accordingly
and died on 27 June. This case-patient was a farm labourer who
had arrived from Bogoso (Western Region) on 24 June prior
to onset of symptoms. He had no history of contact with dead
animals, sick persons or animals and had not attended any social
gathering within three weeks of symptoms onset. The body was
released to family and was buried the traditional way.

The other two cases were relatives of the initial case including
the patient’s 1-year-old son reported on 17 July 2022 who died,
and 24-year-old wife reported on 21 July 2022 who survived
her illness. Separately, another patient presenting with similar
symptoms was suspected to have MVD however this individual
was later found to have tested negative for the virus. All other
patients were laboratory confirmed for MVD at the Noguchi
Memorial Institute for Medical Research and verified by the
Institute Pasteur of Dakar.

Overall, 198 contacts were identified from the cases and only
one reported symptoms. Contact were traced from four districts
Adansi North, Adansi South, Prestea Huni Valley, and SawlaTuna-Kalb
of the Ashanti, Savannah, and West Regions of Ghana
for which patients had exposure. All contacts were discharged
from their monitoring period.

After 42 days after the last case was reported, the Ministry of
Health of Ghana declared the outbreak over on 16 September
2022. The outbreak was also the second one reported in
West Africa following the MVD outbreak in Guinea ending in
September 2021 when one case was reported. Sporadic cases
have been reported in other regions of Africa including Angola,
the Democratic Republic of the Congo, Kenya, South Africa and
Uganda.

PUBLIC HEALTH ACTIONS

Ghana’s National Public Health Emergency Operations Centre
was activated and planned and implemented the response
measures in collaboration with partners.

National support teams were deployed to the affected regions
to provide the necessary support to ensure containment of
the outbreak.

Surveillance activities were implemented including
epidemiological investigation and contact follow up.

Sensitization activities of health care workers on case
definition and infection prevention were carried out.

Ongoing public education and engagements on MVD will be
maintained while the health authorities continuously review
the situation.

The Ministry of health with support from partners initiated
a process for socio-ecological mapping to assess the risk
of viral haemorrhagic fevers for enhanced surveillance in
Ghana.

SITUATION INTERPRETATION

Following roughly two months, Ghana has officially declared over
its Marburg Virus Disease outbreak. Ultimately, only one family
was affected by the outbreak with two succumbing to their illness
demonstrating that high fatality risks faced with MVD infection. A
vigorous investigation and response program including tracing
of almost 200 contacts has contributed to the closure of the
outbreak in a relatively swift manner. However, research must
still be conducted on identifying potential sources of infection by
the initial patient who seemingly did not have contact with the
common methods of disease exposure. Further work is being
conducted among the population to prevent future infections.

https://apps.who.int/iris/bitstream/handle/10665/363154/OEW38-1218082022.pdf
 
Source: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON409


Marburg Virus Disease - Ghana

28 September 2022


Situation at a glance
On 16 September 2022, the Ministry of Health (MoH) of Ghana declared the end of the Marburg Virus Disease (MVD) outbreak that affected the country’s Ashanti, Savannah and Western regions. In accordance with WHO recommendations the declaration was made 42 days (twice the maximum incubation period for Marburg infection) after the second negative test of the last confirmed case on 5 August 2022.
Description of the outbreak
Between 28 June and 16 September 2022, the Ministry of Health of Ghana reported three confirmed cases of Marburg Virus Disease (MVD) including two deaths (CFR 67%). All three cases were from the same household.
The Ministry of Health of Ghana declared the outbreak on 7 July 2022, after confirmation of Marburg virus on 1 July 2022 in a 26-year-old male (the index case) by reverse transcriptase polymerase chain reaction (RT-PCR) at Noguchi Memorial Institute for Medical Research (NMIMR). Blood samples were sent to Institute Pasteur, Dakar for confirmation. The onset of his symptoms was the 22 June with subsequent bleeding from the nose and mouth. The patient was admitted to a hospital on 26 June 2022 and died the following day.
The second patient, a 14-month-old child, developed symptoms and was admitted on 17 July; he died on the third day of admission. The third patient, a 24-year-old female was admitted to a government-designated isolation center on 26 July 2022.
A total of 198 contacts were identified, monitored, and completed their recommended initial 21-day observation period which was then extended for another 21 days by the health authorities.
On 16 September 2022, the MoH declared the end of the outbreak, 42 days (twice the maximum incubation period) after the second negative test of the last confirmed case on 5 August 2022.
Epidemiology of the disease
Marburg Virus Disease (MVD) is an epidemic-prone disease associated with high case fatality ratios (CFR; 24-88%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from many other tropical febrile illnesses due to the similarities in the clinical symptoms. Other VHFs need to be excluded, including Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infections, and plague. Human MVD infection can result from prolonged exposure to mines or caves inhabited by Rousettus bat colonies. Marburg virus spreads through human-to-human transmission via direct contact (through broken skin or mucous membranes) with infected people's blood, secretions, organs or other bodily fluids, and surfaces and materials (e.g. bedding, clothing) contaminated with these fluids.
Although no vaccines or antiviral treatments are approved to treat the virus, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms improve survival. A range of potential treatments are being evaluated, including blood products, immune therapies, and drug therapies.
In 2021, an outbreak of MVD was reported for the first time in West Africa in Guinea. Genetic sequencing results indicated that the Marburg virus (MARV) genomes from Ghana are related to the sequence from the 2021 outbreak and overall, group with sequences obtained from bats in Sierra Leone and an outbreak that occurred in Angola in 2004-2005.

Public health response
  • Overall Response: The MoH established a national coordination mechanism and response activities were initiated by WHO and other key partners, US Center for Disease Control, UNICEF and United Kingdom, Foreign, Commonwealth & Development Office (FCDO). Technical experts were deployed by WHO to support the country in strengthening Infection Prevention and Control (IPC), coordination, surveillance, and to conduct investigations and risk assessment.
  • Surveillance and Contract Tracing: An integrated disease surveillance and response (IDSR) system was in place and reported alerts were tested. Surveillance activities were implemented including epidemiological investigation and 198 contacts were followed up.
  • Infection Prevention and Control: Health care workers were sensitized on case definition and infection prevention.
  • Laboratory: Samples of all suspected cases were tested at the laboratory of NMIMR. Genomic sequencing was performed on samples from two of the confirmed cases at NMIMR and IPD.
  • Community Engagement: Orientation was held for community-based surveillance volunteers to enhance surveillance in the community.
WHO risk assessment

The current outbreak of MVD in Ghana has been declared over, with no new cases reported for 42-days after the second negative test of the last confirmed case on 5 August 2022. This was the first MVD outbreak reported in Ghana. Outbreaks of MVD are not frequent in West Africa. The most recent MVD outbreak was reported in the Republic of Guinea (one confirmed case) in August 2021. Countries in the African Region that have previously reported outbreaks of MVD include Angola, the Democratic Republic of the Congo, Kenya, South Africa, and Uganda.
The epidemiological investigation has not yet identified the source of this outbreak, which highlights the need to intensify community-based surveillance. The risk of this outbreak at its onset was assessed high at the national level, moderate at the regional level, and low at the global level.

WHO advice

Human-to-human transmission of Marburg virus is primarily associated with direct contact with blood and/or bodily fluids of infected persons, and health care related transmission of Marburg virus has been reported when appropriate infection control measures have not been implemented.
Infection Prevention and Control at Health Care Facilities: Health care workers caring for patients with suspected or confirmed Marburg virus disease should apply standard and transmission-based IPC precautions to avoid any exposure to blood and/or bodily fluids, as well as unprotected contact with the possibly contaminated environment. IPC precautions include:
  • Early recognition (screening, triage) and isolation of suspected cases.
  • Appropriate isolation capacity (including infrastructure and human resources).
  • Health care workers’ access to hand hygiene resources (i.e., soap and water or alcohol-based hand rub).
  • Appropriate and accessible PPE for health care workers.
  • Safe injection practices (emphasize on single-use only needles).
  • Procedures and resources for decontamination and sterilization of medical devices.
  • Appropriate management of infectious waste.
Integrated disease surveillance and response activities, including community-based surveillance, must continue to be strengthened within all affected health zones.
Community Awareness for Infection prevention and control: Raising awareness of the risk factors for Marburg virus disease and the protective measures individuals can take to reduce human exposure to the virus are the key measures to reduce human infections and deaths. Key public health communication messages include:
  • Reducing the risk of human-to-human transmission in the community arising from direct contact with infected patients, particularly with their bodily fluids.
  • Avoiding close physical contact with patients who have Marburg virus disease.
  • Any suspected case should not be managed at home, but immediately transferred to a health facility for treatment and isolation. During this transfer, health care workers should wear appropriate PPE.
  • Regular hand washing should be performed after visiting sick relatives in hospital.
  • Communities affected by Marburg should make efforts to ensure that the population is well informed, both about the nature of the disease itself to avoid further transmission, community stigmatization, and encourage early presentation to treatment centers and other necessary outbreak containment measures, including safe burial of the dead. People who have died from Marburg should be promptly and safely buried.
Reduce the risk of wildlife-to-human transmissions, such as through contact with fruit bats, monkeys, and apes:
  • Handle wildlife with gloves and other appropriate protective clothing.
  • Cook animal products such as blood and meat thoroughly before consumption and avoid consumption of raw meat.
  • During work, research activities or tourist visits in mines or caves inhabited by fruit bat colonies, people should wear gloves and other appropriate protective clothing including masks.
Further information
Citable reference: World Health Organization (28 September 2022). Disease Outbreak News; Marburg Virus Disease - Ghana. Available at: https://www.who.int/emergencies/dise...em/2022-DON409
 
Back
Top Bottom